CABA
Price
$2.01
Change
+$0.12 (+6.35%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
339.09M
34 days until earnings call
Intraday BUY SELL Signals
GRDX
Price
$3.80
Change
+$0.36 (+10.47%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
24.74M
Intraday BUY SELL Signals
Interact to see
Advertisement

CABA vs GRDX

CABA vs GRDX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CABA vs. GRDX commentary
Oct 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CABA is a Hold and GRDX is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
CABA vs GRDX: Fundamental Ratings
CABA
GRDX
OUTLOOK RATING
1..100
525
VALUATION
overvalued / fair valued / undervalued
1..100
18
Undervalued
34
Fair valued
PROFIT vs RISK RATING
1..100
10079
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
9048
P/E GROWTH RATING
1..100
10083
SEASONALITY SCORE
1..100
1450

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CABA's Valuation (18) in the null industry is in the same range as GRDX (34). This means that CABA’s stock grew similarly to GRDX’s over the last 12 months.

GRDX's Profit vs Risk Rating (79) in the null industry is in the same range as CABA (100). This means that GRDX’s stock grew similarly to CABA’s over the last 12 months.

CABA's SMR Rating (98) in the null industry is in the same range as GRDX (100). This means that CABA’s stock grew similarly to GRDX’s over the last 12 months.

GRDX's Price Growth Rating (48) in the null industry is somewhat better than the same rating for CABA (90). This means that GRDX’s stock grew somewhat faster than CABA’s over the last 12 months.

GRDX's P/E Growth Rating (83) in the null industry is in the same range as CABA (100). This means that GRDX’s stock grew similarly to CABA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CABAGRDX
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend about 1 month ago
88%
Bullish Trend 11 days ago
86%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
COMPARISON
Comparison
Oct 02, 2026
Stock price -- (CABA: $1.89 vs. GRDX: $3.44)
Brand notoriety: CABA and GRDX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CABA: 204% vs. GRDX: 46%
Market capitalization -- CABA: $339.09M vs. GRDX: $24.74M
CABA [@Biotechnology] is valued at $339.09M. GRDX’s [@Biotechnology] market capitalization is $24.74M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CABA’s FA Score shows that 1 FA rating(s) are green while GRDX’s FA Score has 0 green FA rating(s).

  • CABA’s FA Score: 1 green, 4 red.
  • GRDX’s FA Score: 0 green, 5 red.
According to our system of comparison, GRDX is a better buy in the long-term than CABA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CABA’s TA Score shows that 5 TA indicator(s) are bullish while GRDX’s TA Score has 5 bullish TA indicator(s).

  • CABA’s TA Score: 5 bullish, 6 bearish.
  • GRDX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, GRDX is a better buy in the short-term than CABA.

Price Growth

CABA (@Biotechnology) experienced а -12.30% price change this week, while GRDX (@Biotechnology) price change was -9.71% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.58%. For the same industry, the average monthly price growth was -14.40%, and the average quarterly price growth was -1.79%.

Reported Earning Dates

CABA is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Biotechnology (-3.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
CABA
Daily Signal:
Gain/Loss:
GRDX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
SAND.X0.0449390.001113
+2.54%
The Sandbox cryptocurrency
BNT.X0.3493690.001987
+0.57%
Bancor cryptocurrency
SAGA.X0.0250660.000019
+0.08%
Saga cryptocurrency
XLM.X0.219093-0.007243
-3.20%
Stellar cryptocurrency
UNFI.X0.035305-0.001221
-3.34%
Unifi Protocol DAO cryptocurrency

CABA and

Correlation & Price change

A.I.dvisor indicates that over the last year, CABA has been loosely correlated with NCEL. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if CABA jumps, then NCEL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CABA
1D Price
Change %
CABA100%
-1.56%
NCEL - CABA
45%
Loosely correlated
-0.34%
PRME - CABA
44%
Loosely correlated
-2.13%
NKTX - CABA
44%
Loosely correlated
-2.29%
CGEM - CABA
43%
Loosely correlated
-5.34%
AURA - CABA
41%
Loosely correlated
-3.82%
More

GRDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, GRDX has been loosely correlated with DCOY. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if GRDX jumps, then DCOY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GRDX
1D Price
Change %
GRDX100%
-6.52%
DCOY - GRDX
61%
Loosely correlated
-5.84%
IVVD - GRDX
60%
Loosely correlated
-6.16%
RLMD - GRDX
35%
Loosely correlated
-2.92%
CABA - GRDX
31%
Poorly correlated
-1.56%
IMMP - GRDX
29%
Poorly correlated
-2.37%
More